NO20031697L - New m-amino-phenylimino-imidazoline derivatives for the treatment of urinary incontinence - Google Patents

New m-amino-phenylimino-imidazoline derivatives for the treatment of urinary incontinence

Info

Publication number
NO20031697L
NO20031697L NO20031697A NO20031697A NO20031697L NO 20031697 L NO20031697 L NO 20031697L NO 20031697 A NO20031697 A NO 20031697A NO 20031697 A NO20031697 A NO 20031697A NO 20031697 L NO20031697 L NO 20031697L
Authority
NO
Norway
Prior art keywords
phenylimino
amino
treatment
new
urinary incontinence
Prior art date
Application number
NO20031697A
Other languages
Norwegian (no)
Other versions
NO20031697D0 (en
Inventor
Franz Esser
Jane-Josee Arielle Pasc Pouzet
Hisato Kitagawa
Keiji Sakai
Ikunobu Muramatsu
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20031697D0 publication Critical patent/NO20031697D0/en
Publication of NO20031697L publication Critical patent/NO20031697L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20031697A 2000-10-14 2003-04-11 New m-amino-phenylimino-imidazoline derivatives for the treatment of urinary incontinence NO20031697L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14
PCT/EP2001/011764 WO2002032876A2 (en) 2000-10-14 2001-10-11 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence

Publications (2)

Publication Number Publication Date
NO20031697D0 NO20031697D0 (en) 2003-04-11
NO20031697L true NO20031697L (en) 2003-05-26

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031697A NO20031697L (en) 2000-10-14 2003-04-11 New m-amino-phenylimino-imidazoline derivatives for the treatment of urinary incontinence

Country Status (23)

Country Link
EP (1) EP1328517A2 (en)
JP (1) JP2004511547A (en)
KR (1) KR20030046503A (en)
CN (1) CN1471514A (en)
AR (1) AR035923A1 (en)
AU (1) AU2002215943A1 (en)
BG (1) BG107711A (en)
BR (1) BR0114603A (en)
CA (1) CA2425563A1 (en)
CZ (1) CZ20031333A3 (en)
DE (1) DE10150312A1 (en)
EA (1) EA200300460A1 (en)
EC (1) ECSP034517A (en)
EE (1) EE200300177A (en)
HU (1) HUP0302245A3 (en)
IL (1) IL155338A0 (en)
MX (1) MXPA03003162A (en)
NO (1) NO20031697L (en)
PL (1) PL361359A1 (en)
SK (1) SK4342003A3 (en)
WO (1) WO2002032876A2 (en)
YU (1) YU28203A (en)
ZA (1) ZA200302345B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (en) * 2008-04-16 2008-10-22 国立大学法人福井大学 Imidazoline derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (en) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim NEW SUBSTITUTED 2-PHENYLIMINO-IMIDAZOLIDINE, THEIR ACID-ADDITIONAL SALTS, THESE MEDICINAL PRODUCTS AND METHOD FOR MANUFACTURING THE SAME
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE19514579A1 (en) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Use of alpha-1-olone agonists for the treatment of urinary incontinence

Also Published As

Publication number Publication date
CZ20031333A3 (en) 2003-08-13
EE200300177A (en) 2003-08-15
AU2002215943A1 (en) 2002-04-29
SK4342003A3 (en) 2003-10-07
KR20030046503A (en) 2003-06-12
WO2002032876A2 (en) 2002-04-25
IL155338A0 (en) 2003-11-23
EP1328517A2 (en) 2003-07-23
HUP0302245A3 (en) 2004-01-28
AR035923A1 (en) 2004-07-28
EA200300460A1 (en) 2004-02-26
ECSP034517A (en) 2003-04-25
ZA200302345B (en) 2004-04-23
DE10150312A1 (en) 2002-07-04
PL361359A1 (en) 2004-10-04
YU28203A (en) 2006-05-25
JP2004511547A (en) 2004-04-15
CN1471514A (en) 2004-01-28
WO2002032876A3 (en) 2002-07-18
NO20031697D0 (en) 2003-04-11
BR0114603A (en) 2003-10-14
CA2425563A1 (en) 2002-04-25
HUP0302245A2 (en) 2003-10-28
MXPA03003162A (en) 2004-12-06
BG107711A (en) 2004-02-27

Similar Documents

Publication Publication Date Title
NO20014960D0 (en) New methods of treatment
NO20031442L (en) Morpholine-acetamide derivatives for the treatment of inflammatory diseases
NO20041833L (en) Heterocyclic compounds for use in the treatment of urinary tract disorders
NO20032801D0 (en) Thiazole derivatives for the treatment of PPAR related disorders
NO20024005L (en) Pteridine compounds for the treatment of psoriasis
IL229160B (en) Rapamycin derivatives for the treatment of solid tumors
NO20014950L (en) New methods of treatment
NO20031443D0 (en) Compounds useful for the treatment of inflammatory diseases
IL158050A0 (en) Use of selective cox-2 inhibitors for the treatment of urinary incontinence
PL369062A1 (en) Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
NO20030978L (en) Treatment of urinary dysfunction
NO20026219L (en) Compounds for the treatment of impaired fundic relaxation
AU2002233210A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
NO20012569D0 (en) Use of aryl-substituted cyclobutylamines for the treatment of urinary incontinence
NO20033368L (en) New alkyl-phenylimino-imidazolidine derivatives for the treatment of urinary incontinence
IL162776A0 (en) 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
NO20031697L (en) New m-amino-phenylimino-imidazoline derivatives for the treatment of urinary incontinence
AU2002223688A1 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
HUP0303268A3 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
AU2002233209A1 (en) Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
FI964019L (en) Quinolone derivative for the treatment of urinary incontinence
NO20033428L (en) Use of 2-amino-1 (4-hydroxy-3-methanesulfonamidophenyl) ethanol for the treatment of urinary incontinence
NO20014476L (en) Treatment of hiatial hernia
SI1413305T1 (en) Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
HK1057753A (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application